Impact of age on atrial fibrillation recurrence following surgical ablation
Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved..
OBJECTIVES: The incidence of atrial fibrillation (AF) in patients older than 75 years of age is expected to increase, and its treatment remains challenging. This study evaluated the impact of age on the outcomes of surgical ablation of AF.
METHODS: A retrospective review was performed of patients who underwent the Cox-maze IV procedure at a single institution between 2005 and 2017. The patients were divided into a younger (age <75 years, n = 548) and an elderly cohort (age ≥75 years, n = 148). Rhythm outcomes were assessed at 1 year and annually thereafter. Predictors of first atrial tachyarrhythmia (ATA) recurrence were determined using Fine-Gray regression, allowing for death as the competing risk.
RESULTS: The mean age of the elderly group was 78.5 ± 2.8 years. The majority of patients (423/696, 61%) had nonparoxysmal AF. The elderly patients had a lower body mass index (P < .001) and greater rates of hypertension (P = .011), previous myocardial infarction (P = .017), heart failure (P < .001), and preoperative pacemaker (P = .008). Postoperatively, the elderly group had a greater rate of overall major complications (23% vs 14%, P = .017) and 30-day mortality (6% vs 2%, P = .026). The percent freedom from ATAs and antiarrhythmic drugs was lower in the elderly patients at 3 (69% vs 82%, P = .030) and 4 years (65% vs 79%, P = .043). By competing risk analysis, the incidence of first ATA recurrence was greater in elderly patients (33% vs 20% at 5 years; Gray test, P = .005). On Fine-Gray regression adjusted for clinically relevant covariates, increasing age was identified as a predictor of ATAs recurrence (subdistribution hazard ratio, 1.03; 95% confidence interval, 1.02-1.05, P < .001).
CONCLUSIONS: The efficacy of the Cox-maze IV procedure was worse in elderly patients; however, the majority of patients remained free of ATAs at 5 years. The lower success rate in these greater-risk patients should be considered when deciding to perform surgical ablation.
Errataetall: |
CommentIn: J Thorac Cardiovasc Surg. 2021 Nov;162(5):1530-1533. - PMID 32414592 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:162 |
---|---|
Enthalten in: |
The Journal of thoracic and cardiovascular surgery - 162(2021), 5 vom: 08. Nov., Seite 1516-1528.e1 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
MacGregor, Robert M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Atrial fibrillation |
---|
Anmerkungen: |
Date Completed 01.11.2021 Date Revised 02.11.2022 published: Print-Electronic CommentIn: J Thorac Cardiovasc Surg. 2021 Nov;162(5):1530-1533. - PMID 32414592 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jtcvs.2020.02.137 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309726646 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309726646 | ||
003 | DE-627 | ||
005 | 20231225134542.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jtcvs.2020.02.137 |2 doi | |
028 | 5 | 2 | |a pubmed24n1032.xml |
035 | |a (DE-627)NLM309726646 | ||
035 | |a (NLM)32389465 | ||
035 | |a (PII)S0022-5223(20)30745-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a MacGregor, Robert M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of age on atrial fibrillation recurrence following surgical ablation |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.11.2021 | ||
500 | |a Date Revised 02.11.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: J Thorac Cardiovasc Surg. 2021 Nov;162(5):1530-1533. - PMID 32414592 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved. | ||
520 | |a OBJECTIVES: The incidence of atrial fibrillation (AF) in patients older than 75 years of age is expected to increase, and its treatment remains challenging. This study evaluated the impact of age on the outcomes of surgical ablation of AF | ||
520 | |a METHODS: A retrospective review was performed of patients who underwent the Cox-maze IV procedure at a single institution between 2005 and 2017. The patients were divided into a younger (age <75 years, n = 548) and an elderly cohort (age ≥75 years, n = 148). Rhythm outcomes were assessed at 1 year and annually thereafter. Predictors of first atrial tachyarrhythmia (ATA) recurrence were determined using Fine-Gray regression, allowing for death as the competing risk | ||
520 | |a RESULTS: The mean age of the elderly group was 78.5 ± 2.8 years. The majority of patients (423/696, 61%) had nonparoxysmal AF. The elderly patients had a lower body mass index (P < .001) and greater rates of hypertension (P = .011), previous myocardial infarction (P = .017), heart failure (P < .001), and preoperative pacemaker (P = .008). Postoperatively, the elderly group had a greater rate of overall major complications (23% vs 14%, P = .017) and 30-day mortality (6% vs 2%, P = .026). The percent freedom from ATAs and antiarrhythmic drugs was lower in the elderly patients at 3 (69% vs 82%, P = .030) and 4 years (65% vs 79%, P = .043). By competing risk analysis, the incidence of first ATA recurrence was greater in elderly patients (33% vs 20% at 5 years; Gray test, P = .005). On Fine-Gray regression adjusted for clinically relevant covariates, increasing age was identified as a predictor of ATAs recurrence (subdistribution hazard ratio, 1.03; 95% confidence interval, 1.02-1.05, P < .001) | ||
520 | |a CONCLUSIONS: The efficacy of the Cox-maze IV procedure was worse in elderly patients; however, the majority of patients remained free of ATAs at 5 years. The lower success rate in these greater-risk patients should be considered when deciding to perform surgical ablation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Webcast | |
650 | 4 | |a Cox maze procedure | |
650 | 4 | |a atrial fibrillation | |
650 | 4 | |a elderly | |
650 | 4 | |a long-term outcomes | |
650 | 4 | |a surgical ablation | |
700 | 1 | |a Khiabani, Ali J |e verfasserin |4 aut | |
700 | 1 | |a Bakir, Nadia H |e verfasserin |4 aut | |
700 | 1 | |a Manghelli, Joshua L |e verfasserin |4 aut | |
700 | 1 | |a Sinn, Laurie A |e verfasserin |4 aut | |
700 | 1 | |a Carter, Daniel I |e verfasserin |4 aut | |
700 | 1 | |a Maniar, Hersh S |e verfasserin |4 aut | |
700 | 1 | |a Moon, Marc R |e verfasserin |4 aut | |
700 | 1 | |a Schuessler, Richard B |e verfasserin |4 aut | |
700 | 1 | |a Melby, Spencer J |e verfasserin |4 aut | |
700 | 1 | |a Damiano, Ralph J |c Jr |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of thoracic and cardiovascular surgery |d 1959 |g 162(2021), 5 vom: 08. Nov., Seite 1516-1528.e1 |w (DE-627)NLM000033510 |x 1097-685X |7 nnns |
773 | 1 | 8 | |g volume:162 |g year:2021 |g number:5 |g day:08 |g month:11 |g pages:1516-1528.e1 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jtcvs.2020.02.137 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 162 |j 2021 |e 5 |b 08 |c 11 |h 1516-1528.e1 |